|
|
Product trade name: Venoruton Forte
| Pharmaceutical active ingredients: |
| Monoxerutin |
| Available forms, composition and doses of Venoruton Forte: |
| Tablets; Oral; Monoxerutin 500 mg |
| Venoruton Forte medical category: |
| Human:Anorectal preparationsPhlebitis and varicose preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C05CA02 - Monoxerutin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisZuellig Pharma |
Pharmaceutical drugs, medications and other health products with similar to Venoruton Forte trade names:
Compare some medical and health care products with the same or related to Venoruton Forte active ingredients:
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Menalgon | Monophosphothiamine; Vitamin B12 (Cyanocobalamin) | Fidia Farmaceutici | | Menalgon B6 | Monophosphothiamine; Vitamin B12 (Cyanocobalamin); Vitamin B6 (Pyridoxine Hydrochloride) | Fidia Farmaceutici | | Dextro OG-T | Monosaccharides; Oligosaccharides | Roche | | Rutilemone | Monoxerutin | Unidentified Pharmaceutical Company | | Venoruton | Monoxerutin | Novartis; Gebro Pharma; Zuellig Pharma | | Admont | Montelukast | Adley Formulation | | Airway | Montelukast | Intra Labs India | | Asventol | Montelukast | Chile Laboratorios | | Brondilat | Montelukast | Recalcine Laboratorios | | Kast | Montelukast | RND Laboratories |
More pharmaceutical products manufactured or supplied by the same as Venoruton Forte and similar pharmaceutical companies:
Comments
Raymond de Zeeuw
01 Oct 2009, 23:57
Dear Sir/Mme,
I have a question about the use of Venoruton. Some of my collegues use
Venoruton 5 days before they start treating their patients with small
varicose veins and a dark skin. They tell me that the chance of creating a
pigmentation after sclerotherapy is much lower using Venoruton before the
treatment. Has this been proven yet? Are you familair with this side
effect?
I hope you can give me some info about this?
Best regards,
Raymond de Zeeuw
|
|